The Instantsure Rapid SARS-CoV-2 Antigen Test Card, is registered in Italy and Peru for use and currently are in the final evaluation stages with SAHPRA to gain registration in South Africa to be distributed. This test are only to be performed by health professionals.
This product is cost-effective and a rapid point-of-care solution. With individually packaged buffer solutions for every test, minimizing possible buffer contamination, this product a valuable prospect for self testing solutions or non professional.
Instantsure antigen tests from Saiertech detects antigen based on the viral nucleocapsid protein coded by the very stable N gene.
Sensitivity (Positive incidence rate): 93,5%
Specificity (Negative incidence rate): 99,2%
Total coincidence rate: 99,2%
Thola Biotechnologies is a subsidiary of Elu Healthcare Holdings, an African based biotechnology company that was formed to provide solutions to the medical services sector, born out of the Coronavirus pandemic.
Thola Biotechnologies © 2021 | Website Design by Versys Media